Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Jack

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
BMJ (Clinical Research Ed.)|September 10, 2016
PrEP, Truvada, and GileadAndrew Jack
BMJ (Clinical Research Ed.)|October 13, 2011
Letting the sunshine in on doctor-pharma relationshipsAndrew Jack
BMJ (Clinical Research Ed.)|April 11, 2009
Commentary: Look after the penniesAndrew Jack
BMJ (Clinical Research Ed.)|September 22, 2009
Flu's unexpected bonusAndrew Jack
BMJ (Clinical Research Ed.)|December 3, 2008
Legal tactics to delay launch of generic drugs cost Europe euro3bn, report saysAndrew Jack
BMJ (Clinical Research Ed.)|May 23, 2009
The problem with flu vaccinesAndrew Jack
BMJ (Clinical Research Ed.)|September 6, 2013
Drug Development. Compound interests: how a partnership between academics and a drug company came unstuckAndrew Jack
BMJ (Clinical Research Ed.)|July 9, 2013
Bring me sunshine: EU drug companies make payments to doctors publicAndrew Jack
BMJ (Clinical Research Ed.)|February 11, 2014
Drug patents cause fresh spat between South Africa and industryAndrew Jack
BMJ (Clinical Research Ed.)|July 20, 2012
Mea culpa: are multi-billion dollar fines forcing drug companies to clean up their act?Andrew Jack
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
BMJ (Clinical Research Ed.)|September 10, 2016
PrEP, Truvada, and GileadAndrew Jack
BMJ (Clinical Research Ed.)|October 13, 2011
Letting the sunshine in on doctor-pharma relationshipsAndrew Jack
BMJ (Clinical Research Ed.)|April 11, 2009
Commentary: Look after the penniesAndrew Jack
BMJ (Clinical Research Ed.)|September 22, 2009
Flu's unexpected bonusAndrew Jack
BMJ (Clinical Research Ed.)|December 3, 2008
Legal tactics to delay launch of generic drugs cost Europe euro3bn, report saysAndrew Jack
BMJ (Clinical Research Ed.)|May 23, 2009
The problem with flu vaccinesAndrew Jack
BMJ (Clinical Research Ed.)|September 6, 2013
Drug Development. Compound interests: how a partnership between academics and a drug company came unstuckAndrew Jack
BMJ (Clinical Research Ed.)|July 9, 2013
Bring me sunshine: EU drug companies make payments to doctors publicAndrew Jack
BMJ (Clinical Research Ed.)|February 11, 2014
Drug patents cause fresh spat between South Africa and industryAndrew Jack
BMJ (Clinical Research Ed.)|July 20, 2012
Mea culpa: are multi-billion dollar fines forcing drug companies to clean up their act?Andrew Jack
Pageof 10